We are live on ! Find out more
DSCI

Derma Sciences, Inc. Common Stock (DE)
DSCI

Delisted

DSCI was delisted on the 23rd of February, 2017.

Back to rankings

55 hedge funds and large institutions have $93.6M invested in Derma Sciences, Inc. Common Stock (DE) in 2015 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 20 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% less funds holding

Funds holding: 62 → 55 (-7)

15% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 20

46% less capital invested

Capital invested by funds: $172M → $93.6M (-$78.8M)

50% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 14

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $35K

Holders
55
Holders Change
-7
Holders Change %
-11.29%
% of All Funds
1.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
17
Reduced
20
Closed
14
Calls
–
Puts
$35K
Net Calls
-$35K
Net Calls Change
-$20K

Top Buyers

Rank Fund Capital Flow
1
GTC
Ghost Tree Capital
New York
+$1.94M
2
CCM
Consonance Capital Management
New York
+$858K
3
Citadel Advisors
Citadel Advisors
Florida
+$463K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$304K
5
BC
Broadfin Capital
New York
+$288K

Top Sellers

Rank Fund Capital Flow
1
SPPAM
Summit Partners Public Asset Management
Massachusetts
-$1.64M
2
GPP
Great Point Partners
Connecticut
-$1.15M
3
JGC
J. Goldman & Co
New York
-$1.14M
4
RA
Royce & Associates
New York
-$1.1M
5
Northern Trust
Northern Trust
Illinois
-$1.03M
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$16.3M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$11.7M – – –
BC
3
Broadfin Capital
New York
$11.1M +$288K +44,615 +2%
CCM
4
Consonance Capital Management
New York
$8.92M +$858K +132,818 +8%
SM
5
Senvest Management
New York
$5.43M – – –
Jennison Associates
6
Jennison Associates
New York
$5.4M +$33.8K +5,242 +0.5%
DM
7
Deerfield Management
New York
$4.72M +$215K +33,320 +3%
Vanguard Group
8
Vanguard Group
Pennsylvania
$2.78M +$181K +28,033 +5%
GIM
9
Granahan Investment Management
Massachusetts
$2.38M -$189K -29,300 -5%
Millennium Management
10
Millennium Management
New York
$2.21M -$427K -66,108 -12%
JGC
11
J. Goldman & Co
New York
$2.1M -$1.14M -177,200 -28%
Adage Capital Partners
12
Adage Capital Partners
Massachusetts
$1.88M – – –
PA
13
Perceptive Advisors
New York
$1.7M +$76.2K +11,800 +3%
DCM
14
DAFNA Capital Management
California
$1.68M -$110K -17,000 -5%
Fidelity International
15
Fidelity International
Bermuda
$1.47M – – –
GTC
16
Ghost Tree Capital
New York
$1.41M +$1.94M +300,000 New
Renaissance Technologies
17
Renaissance Technologies
New York
$1.32M -$651K -100,907 -26%
RAM
18
Roanoke Asset Management
New Jersey
$1.29M – – –
RA
19
Royce & Associates
New York
$1.04M -$1.1M -170,993 -44%
D.E. Shaw & Co
20
D.E. Shaw & Co
New York
$943K +$304K +47,088 +31%
PI
21
Putnam Investments
Massachusetts
$844K -$4.97K -770 -0.4%
Goldman Sachs
22
Goldman Sachs
New York
$813K -$261K -40,428 -19%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$805K +$38.2K +5,915 +4%
Geode Capital Management
24
Geode Capital Management
Massachusetts
$600K -$21.7K -3,356 -3%
UBS AM
25
UBS AM
Illinois
$497K +$7.89K +1,222 +1%
1
2 3

DSCI Hedge Fund Activity: Q3 2015 in Review

55 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Derma Sciences, Inc. Common Stock (DE) (DSCI) for Q3 2015, worth a combined $93.6M — down 46% from $172M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of DSCI and 7 opened new positions — a net loss of 7 holders — while 20 trimmed existing stakes and 17 added.

The largest buyer was Ghost Tree Capital, opening a new position worth an estimated $1.94M. The largest seller was Summit Partners Public Asset Management, cutting an estimated $1.64M.

  • 55 institutional investors held Derma Sciences, Inc. Common Stock (DE) (DSCI) as of Q3 2015, down from 62 in Q2 2015.
  • Funds reported $93.6M of Derma Sciences, Inc. Common Stock (DE) stock for Q3 2015, down 46% quarter-over-quarter.
  • 7 funds opened new Derma Sciences, Inc. Common Stock (DE) positions in Q3 2015 and 14 closed out, a net change of -7 holders.
  • The largest Derma Sciences, Inc. Common Stock (DE) buyer in Q3 2015 was Ghost Tree Capital, an estimated $1.94M added.
  • The largest Derma Sciences, Inc. Common Stock (DE) seller in Q3 2015 was Summit Partners Public Asset Management, an estimated $1.64M sold.

Based on aggregated 13F filings for Q3 2015.